1. Home
  2. RTX vs SNY Comparison

RTX vs SNY Comparison

Compare RTX & SNY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RTX
  • SNY
  • Stock Information
  • Founded
  • RTX 1934
  • SNY 1994
  • Country
  • RTX United States
  • SNY France
  • Employees
  • RTX N/A
  • SNY N/A
  • Industry
  • RTX Aerospace
  • SNY Biotechnology: Pharmaceutical Preparations
  • Sector
  • RTX Industrials
  • SNY Health Care
  • Exchange
  • RTX Nasdaq
  • SNY Nasdaq
  • Market Cap
  • RTX 208.6B
  • SNY 113.4B
  • IPO Year
  • RTX N/A
  • SNY N/A
  • Fundamental
  • Price
  • RTX $158.20
  • SNY $47.68
  • Analyst Decision
  • RTX Buy
  • SNY Buy
  • Analyst Count
  • RTX 13
  • SNY 4
  • Target Price
  • RTX $162.62
  • SNY $61.50
  • AVG Volume (30 Days)
  • RTX 3.9M
  • SNY 2.8M
  • Earning Date
  • RTX 10-21-2025
  • SNY 10-24-2025
  • Dividend Yield
  • RTX 1.72%
  • SNY 3.35%
  • EPS Growth
  • RTX 174.23
  • SNY 118.56
  • EPS
  • RTX 4.55
  • SNY 8.65
  • Revenue
  • RTX $83,599,000,000.00
  • SNY $53,714,621,258.00
  • Revenue This Year
  • RTX $7.01
  • SNY $1.53
  • Revenue Next Year
  • RTX $5.90
  • SNY $7.06
  • P/E Ratio
  • RTX $34.78
  • SNY $5.52
  • Revenue Growth
  • RTX 15.44
  • SNY 15.65
  • 52 Week Low
  • RTX $112.27
  • SNY $44.73
  • 52 Week High
  • RTX $161.26
  • SNY $60.12
  • Technical
  • Relative Strength Index (RSI)
  • RTX 55.02
  • SNY 47.66
  • Support Level
  • RTX $155.71
  • SNY $46.50
  • Resistance Level
  • RTX $159.95
  • SNY $47.69
  • Average True Range (ATR)
  • RTX 2.59
  • SNY 0.69
  • MACD
  • RTX -0.03
  • SNY -0.10
  • Stochastic Oscillator
  • RTX 72.35
  • SNY 49.44

About RTX RTX Corporation

RTX is an aerospace and defense manufacturer formed from the merger of United Technologies and Raytheon, with roughly equal exposure as a supplier to commercial aerospace and to the defense market across three segments: Collins Aerospace, a diversified aerospace supplier; Pratt & Whitney, a commercial and military aircraft engine manufacturer; and Raytheon, a defense prime contractor providing a mix of missiles, missile defense systems, sensors, hardware, and communications technology to the military.

About SNY Sanofi ADS

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Share on Social Networks: